Target-AID (pRZ762) Citations (3)
Originally described in: CRISPR DNA base editors with reduced RNA off-target and self-editing activities.Grunewald J, Zhou R, Iyer S, Lareau CA, Garcia SP, Aryee MJ, Joung JK Nat Biotechnol. 2019 Sep 2. pii: 10.1038/s41587-019-0236-6. doi: 10.1038/s41587-019-0236-6. PubMed Journal
Articles Citing Target-AID (pRZ762)
| Articles |
|---|
A dual-deaminase CRISPR base editor enables concurrent adenine and cytosine editing.
Grunewald J, Zhou R, Lareau CA, Garcia SP, Iyer S, Miller BR, Langner LM, Hsu JY, Aryee MJ, Joung JK.
Nat Biotechnol. 2020 Jun 1. pii: 10.1038/s41587-020-0535-y. doi: 10.1038/s41587-020-0535-y.
PubMed
Associated Plasmids |
| Predicting base editing outcomes with an attention-based deep learning algorithm trained on high-throughput target library screens. Marquart KF, Allam A, Janjuha S, Sintsova A, Villiger L, Frey N, Krauthammer M, Schwank G. Nat Commun. 2021 Aug 25;12(1):5114. doi: 10.1038/s41467-021-25375-z. PubMed |
| Genotoxicity profiling reveals distinct platform-and cell type-specific effects in therapeutic gene editing for genetic hyperinflammation. Lei L, Kaufmann MM, Lao J, Thoulass G, Ammann S, Xiao H, Rhiel M, Dettmer-Monaco V, Grunewald J, Andrieux G, Alzubi J, Miller BR, Weissert K, Grassel L, Schell C, Illert AL, Joung JK, Boerries M, Cornu TI, Ehl S, Erlacher M, Aichele P, Cathomen T. Cell Stem Cell. 2026 Jun 4;33(6):930-944.e5. doi: 10.1016/j.stem.2026.04.014. Epub 2026 May 13. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.